Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Market Size and Growth
The SGLT2 inhibitors market is experiencing significant growth, driven by increasing diabetes prevalence and rising awareness of cardiovascular benefits. In 2023, the global market size is estimated at approximately $8 billion, with consistent expansion expected due to emerging therapies and ongoing research, enhancing treatment options for diabetes management and related conditions.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Eli Lilly
◍ Boehringer Ingelheim
◍ Janssen Pharmaceuticals
◍ Kotobuki Pharmaceutical
◍ Astellas
◍ Bristol Myers Squibb
◍ AstraZeneca
The SGLT2 inhibitors market features key players like Eli Lilly, Boehringer Ingelheim, and AstraZeneca, developing innovative therapies to enhance diabetes management and cardiovascular health. Their strategic partnerships, research investments, and market expansion initiatives drive growth. Sales revenues include AstraZeneca's ~$6 billion and Johnson & Johnson's ~$3 billion from SGLT2 products. Request Sample Report
